By MoH order No. 593 of 12.07.13 and order No. 615 of 18.07.13, the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal product containing sulpiride, namely Eglonyl, capsules, tablets, solution for injection, were approved with amendments and additions to the following sections of the instructions: "Contraindications", "Adverse reactions", "Use during pregnancy or breastfeeding", "Special warnings and precautions for use", "Interaction with other medicinal products and other forms of interaction".
List of medicinal products containing sulpiride as an active ingredient, authorized for medical use in Ukraine.
